| CTNT 0.1608 -5.80% | ZSPC 0.0871 21.48% | ONFO 1.5 124.89% | MYSE 3.3 129.17% | NVDA 198.35 -0.26% | BITO 10.35 0.49% | TZA 5.43 -0.46% | TSLL 13.07 -1.73% | INTC 68.5 5.48% | CAPS 0.5345 -9.25% | HUBC 0.1833 -29.50% | DVLT 0.8375 19.63% | SOXS 20.28 -3.13% | TQQQ 56.43 1.40% | QBTS 21.505 3.34% | AGAE 0.5219 10.57% | HIMS 26.99 11.12% | IONQ 44.68 3.31% | DGNX 0.5556 -0.79% | GRAB 4.02 2.55% | SNAP 6.02 -0.33% | SOFI 19.03 1.28% | SMR 11.41 -2.56% | TSLA 388.9 -0.78% | ITP 0.2 -3.57% | BMNG 1.53 0.66% | SOXL 88.37 2.80% | AMD 278.26 7.80% | RGTI 19.45 1.78% | OPEN 5.27 9.34% | MDCX 0.3003 -0.60% | PLUG 2.86 -2.39% | MARA 11.55 10.32% | NVD 5.81 0.69% | AAL 12.27 0.82% | SQQQ 58.61 -1.40% | IMMP 0.5796 6.54% | HOOD 86.85 -0.54% | ONDS 10.2 1.69% | NVTS 12.37 20.57% | RMSG 2.55 42.46% | BYND 0.782 4.11% | NOK 10.29 3.00% | NFLX 107.79 0.07% | ORCL 178.46 5.09% | SPY 701.66 0.25% | SOUN 7.7 -1.91% | AAPL 263.4 -1.14% | PBM 5.87 103.82% | PLTR 142.76 0.43%

Procter & Gamble Reports Flat Organic Sales as U.S. Spending Remains Pressured

Procter & Gamble (NYSE: PG) reported flat organic sales growth for its fiscal second quarter, as the consumer products giant faced a challenging spending environment in the United States.

The company said organic sales, which exclude the impact of foreign exchange and acquisitions or divestitures, were unchanged for the quarter ended December. Bloomberg consensus estimates had called for growth of 0.54%.

P&G noted that price increases were fully offset by an equal decline in volumes. Strength in the company’s beauty and health care segments was offset by weaker performance in grooming, home care and baby care.

Net sales increased 1% year over year to $22.2 billion, slightly below Wall Street expectations of $22.32 billion.

Core earnings per share were $1.88, unchanged from the prior year and modestly above analyst projections of $1.86.

Published on: January 22, 2026